CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biotec Pharmacon ASA Company Snapshot
Biotec Pharmacon ASA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biotec Pharmacon ASA with three other pharmaceutical manufacturers in Europe: Dbv Technologies of France (2016 sales of 9.08 million Euro [US$10.59 million] of which 100% was Research & Development), Swedencare AB (publ) of Sweden (53.72 million Swedish Kronor [US$6.54 million] ), and Unipharm AD which is based in Bulgaria (17.70 million Bulgarian Lev [US$10.53 million] ).

Sales Analysis. During the year ended December of 2016, sales at Biotec Pharmacon ASA were NOK 71.90 million (US$9.02 million). This is an increase of 35.0% versus 2015, when the company's sales were NOK 53.28 million. This was the fourth straight year of sales growth at Biotec Pharmacon ASA.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biotec Pharmacon ASA
  Stock Performance Chart for Biotec Pharmacon ASA
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 5.50
(Figures in Norwegian Kroner)
1 Week 3.8%   13 Weeks 0.7%  
4 Weeks -35.3%   52 Weeks -48.6%  
 
Biotec Pharmacon ASA Key Data:
  Ticker: BIOTEC Country: Norway
  Exchanges: OSL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 71,904,000
(Year Ending Jan 2017).
Employees: 41
  Currency: Norwegian Kroner Market Cap: 241,695,702
  Fiscal Yr Ends: December Shares Outstanding: 43,944,673
  Share Type: Ordinaere Aksje Closely Held Shares: 11,529,653
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.